Technology platform offer

My group provides a combination of fundamental nanotechnology engineering and clinical translation capabilities:

• Custom Functionalized Biomaterials: Proprietor of a highly versatile, programmable SAP platform. We synthesize synthetic hydrogels featuring tailor-made mechano-chemical and viscoelastic profiles (adjusting rheology, degradation rates, and cell-signaling motifs).

• Stem Cell & 3D Tissue Engineering: Extensive expertise in instruction and long-term 3D cultivation of human somatic and stem cells within synthetic matrices, successfully inducing structural maturation and tissue-like integration.

• In Vivo & Pre-clinical Validation: Robust track record in establishing rigorous pre-clinical animal models (e.g., spinal cord injury transections, contusions, and lesion repairs) to assess functional tissue recovery, vascular differentiation, and material biocompatibility.

• State-of-the-Art Infrastructure: Complete access to molecular biology suites, peptide synthesis facilities, advanced rheology and nano-characterization equipment, high-resolution SEM, AFM, ATR-FTIR, and dedicated pre-clinical imaging rooms.

Expected Role in the Consortium

We aim to participate as a high-contribution Work Package (WP) Leader or core Research Partner. We are ready to drive work packages focused on:

• WP: Biomaterial Engineering & Custom Scaffold Fabrication (molecular design, synthesis, and characterization of path-specific hydrogels).

• WP: In Vitro 3D Disease Modeling / Cell-Matrix Interaction Assessments (optimizing stem cell differentiation, migration, and survival).

• WP: Pre-clinical Efficacy & Translational Validation (in vivo testing, histopathology, functional recovery evaluation).